Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension.
about
The role of urotensin II in cardiovascular and renal physiology and diseasesRole of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstrictionSkin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication.Urotensin II in chronic liver disease: in vivo effect on vascular tone.The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.Evaluation of the effects of urotensin II and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients.Urotensin II alters vascular reactivity in animals subjected to volume overload.Hemodynamic effects of chronic urotensin II administration in animals with and without aorto-caval fistulaAssociation between human urotensin II and essential hypertension--a 1:1 matched case-control studyThe peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systemsPotential Clinical Implications of the Urotensin II Receptor Antagonists.A closer look at the role of urotensin II in the metabolic syndrome.Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?Blockade of Urotensin II Receptor Prevents Vascular Dysfunction.Urotensin II in cardiovascular regulation.Role of urotensin II in health and disease.Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy.The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans.The Role of Human Urotensin-II in Patients with Hypertrophic Cardiomyopathy.
P2860
Q24675590-760E3C81-27F1-44B1-BD48-591F56A4F1F2Q28572971-A3EDD98D-BE41-4481-A527-4D0D1F6DD8B0Q33345385-5B38F7BB-6585-4E2D-BB6D-83EB6E992D74Q33378279-65B0AD81-5531-4197-9C5E-62D1DF523F80Q33599835-6A49EA6E-883D-418B-B798-98D66E2E5D4CQ34007711-AB401C7E-08B6-4028-B8D9-7823B91B77D8Q34192302-B9470DCD-3D66-4C41-B716-D773AB7919C9Q34248766-46595CF7-A3F3-4760-9B1A-BF3D39B40C80Q35067629-675DCEE1-43B9-4523-9C85-CB2FBAD76D4AQ35100902-10AD8F64-4C2D-4CA7-BCE9-AA532B09A8CCQ35128456-95A98E83-2F4D-4E3E-A04A-D05B51D316FEQ36492706-C7E648FB-2690-4778-AC2E-42B3B2C728E0Q37082781-1791337F-16A2-4DD9-8441-EC6FBE07E2C1Q37235264-4F76EB63-DC92-4F92-9B0F-18B6BF2CD6A1Q37344439-35F0A155-A949-48DA-84B6-69E134FA42FEQ37737495-A88E7C6D-1485-41B2-BCA2-FC4254B1549EQ38196857-3F531290-DB26-4DC1-B905-A001268078C5Q42283626-2E464D99-E5B1-4273-A207-C8E8F1669017Q47706645-A943EBA9-3A89-4B44-AA50-766E041723B0
P2860
Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of exogenous urotensin- ...... s with essential hypertension.
@ast
Effect of exogenous urotensin- ...... s with essential hypertension.
@en
type
label
Effect of exogenous urotensin- ...... s with essential hypertension.
@ast
Effect of exogenous urotensin- ...... s with essential hypertension.
@en
prefLabel
Effect of exogenous urotensin- ...... s with essential hypertension.
@ast
Effect of exogenous urotensin- ...... s with essential hypertension.
@en
P2093
P1476
Effect of exogenous urotensin- ...... s with essential hypertension.
@en
P2093
Andrew Kompa
Brigitte Sondermeijer
Paul Komesaroff
P304
P356
10.1016/J.AMJHYPER.2005.03.748
P433
P50
P577
2005-09-01T00:00:00Z